
Leveraging T cell genetic variants to enhance mela...
Zachary Walsh’s Abstract T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly pro...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Zachary Walsh’s Abstract T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly pro...
Amanda Zucker’s Abstract Uveal melanoma (UM) is a rare but lethal cancer of the eye. Despite initial successful treatment, 50% of patients experience spread of the ca...
Yingjoy Li’s Abstract Melanoma is the deadliest type of skin cancer. Although it mostly affects people with lighter skin, those with darker skin, including Asian, Asi...
Jordan Bui’s Abstract The use of artificial intelligence (AI) in dermatology is becoming increasingly prevalent and advancing rapidly. Current research has demonstrat...
Jack Kollings’ Abstract Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapyâ...
Kimberly Nguyen’s Abstract Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, bring...
Anjali Devireddy’s Abstract Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The prese...
Oct 16, 2025 ET
Oct 30, 2025 ET